This page contains a Flash digital edition of a book.
Pain agonists, Anesthesiology, 2000;93:1345–9.


64. Leiphart JW, Dills CV, Levy RM, Alpha2-adrenergic receptor subtype specificity of intrathecally administered tizanidine used for analgesia for neuropathic pain, J Neurosurg, 2004;101:641–7.


65. Eisenach JC, Three novel spinal analgesics: clonidine, neostigmine, amitriptyline, Reg Anesth, 1996;21:81–3.


66. Roh D, Kim HW, Yoon SY, et al., Intrathecal clonidine suppresses phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit in spinal dorsal horn neurons of rats with neuropathic pain, Anesth Analg, 2008;107:693–700.


67. Yao XH, Zhou P, Huang Y, et al., Effects of intrathecal escin and clonidine in the treatment of neuropathic pain in rats, Nan Fang Yi Ke Da Xue Xue Bao, 2009;29:1840–2.


68. Rauck RL, Eisenach JC, Jackson K, et al., Epidural clonidine treatment for refractory reflex sympathetic dystrophy, Anesthesiology, 1993;179:1163–9.


69. Ackerman LL, Follett KA, Rosenquist RW, Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opiod combinations, J Symptom Pain Manage, 2003;26:668–77.


70. Siddall PJ, Molloy AR, Walker S, et al., The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury, Anesth Analg, 2000;91:1493–8.


71. Eisenach JC, Hood DD, Curry R, Intrathecal, but not intravenous clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers, Anesth Analg, 1998;87:591–6.


72. Puke MJ, Wiesenfeld-Hallin Z, The differential effects of the alpha 2-adrenocepter agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain, Anesth Analg, 1993;77:104–9.


73. Xu M, Kontinen VK, Kalso E, Effects of radolmidine, a novel alpha 2-adrenergic agonist compared with dexmedetomidine in different pain models in the rat, Anesthesiology, 2000;93:473–81. 74. Kanazi GE, Aouad MT, Jabour-Khoury SI, et al., Effect of low-


dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block, Acta Anaesthesiol Scand, 2006;50:222–7.


75. Kawamata T, Omote K, Yamamoto H, Antihyperalgesic and side effects of intrathecal clonidine and tizanidine in a rat model of neuropathic pain, Anesthesiology, 2003;98:1480–3.


76. Semenchuk MR, Sherman S, Effectiveness of tizanidine in neuropathic pain: an open label study, J Pain, 2000;1:285–92.


77. Chrousos GP, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation, N Engl J Med, 1995;332:1351–62.


78. Greaves MW, Anti-inflammatory action of corticosteroids, Postgrad Med J, 1976;52:631–3.


79. Roche J, Steroid-induced arachnoiditis, Med J Aust, 1984;140:281–4. 80. Nelson DA, Dangers from methylprednisolone acetate therapy by intraspinal injection, Arch Neurol, 1988;45:804–6.


81. Wilkinson HA, Intrathecal Depo-Medrol: a literature review, Clin J Pain, 1992;8:49–56.


82. Argoff CE, Review of current guidelines on the care of postherpetic neuralgia, Postgrad Med, 2011;123:134–42.


83. Donahue JG, Choo PW, Manson JE, et al., The incidence of herpes zoster, Arch Intern Med, 1995;155:1605–9.


84. Balfour HH, Bean B, Laskin OL, et al.; Burroughs Wellcome Collaborative AcyclovirStudy Group, Acyclovir halts progression of herpes zoster in immunocompromised patients, N Engl J Med, 1983;308:1448–53.


85. Wood MJ, Johnson RW, McKendrick MW, et al., A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster, N Engl J Med, 1994;330:896–900.


86. Bowsher D, The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial, J Pain Symptom Manage, 1997;13:327–31.


87. Oxman MN, Levin MJ, Johnson GR, et al.; Shingles Prevention Study Group, A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults, N Engl J Med,


2005;325:2271–84.


88. Watson P, Postherpetic neuralgia, Am Fam Physician, 2011;84:690–2. 89. Kikucki A, Kotani N, Sato T, et al., Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia, Reg Anesth Pain Med, 1999;24:287–93.


90. Kotani N, Kushikata T, Hashimoto H, et al., Intrathecal methylprednisolone for intractable postherpetic neuralgia, N Engl J Med, 2000;343:1514–9.


91. Candido KD, Knezevic I, Mukalel J, Knezevic NN, Enhancing the relative safety of intentional or unintentional intrathecal methylprednisolone administration by removing polyethylene glycol, Anesth Analg, 2011; (Epub ahead of print).


92. Kumar K, Kelly M, Pirlot T, Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy, Surg Neurol, 2001;55:79–86.


93. Anderson VC, Burchiel KJ, A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain, Neurosurgery, 1999;44:289–300.


94. Angel IF, Gould HJ Jr, Carey ME, Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin, Surg Neurol, 1998;49:92–8.


95. Hassenbusch SJ, Stanton-Hicks M, Covington EC, et al., Long-term intraspinal infusions of opioids in the treatment of neuropathic pain, J Pain Symptom Manage, 1995;10:527–43.


96. Webster LR, Fisher R, Charapata S, et al., Long-term intrathecal ziconotide for chronic pain: an open-label study, J Pain Symptom Manage, 2009;37:363–72.


97. Goucke CR, Dusci LJ, Van Leeuwen S, et al., Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study, Pain Med, 2010;11:1612–8.


98. Heetla HW, Staal MJ, Kliphuis C, et al., The incidence and management of tolerance in intrathecal baclofen therapy, Spinal Cord, 2009;47:751–6.


162


US NEUROLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108